Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28

Reuters

07/23

Thermo Fisher Scientific <a href="https://laohu8.com/S/QTWO">Q2</a> 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28

Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share $(EPS)$, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2553939219"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553939219\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553939219?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 18:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553939219","market":"us","top_or_hot":-1,"title":"Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Thermo Fisher Scientific <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share <a href=\"https://laohu8.com/S/EPS\">$(EPS)$</a>, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-07-23 18:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Thermo Fisher Scientific <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share <a href=\"https://laohu8.com/S/EPS\">$(EPS)$</a>, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMO","symbol_name":"賽默飛世爾","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL2Lnv3y:1","article_id":"2553939219","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553939219","pubTimestamp":1753264840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share , which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TMO":"赛默飞世尔"},"translate_title":"Thermo Fisher Scientific 2025年第二季度：收入增长3%至$10.85 B，GAAP每股收益增长6%至$4.28","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMO":0.9},"content_text":"Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28\n    \n\n        Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share $(EPS)$, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}